Linfomas
GLUN
Universidad Pública de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Universidad Pública de Navarra (9)
2023
-
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma
Nature Medicine, Vol. 29, Núm. 3, pp. 632-645
2022
-
Two cell line models to study multiorganic metastasis and immunotherapy in lung squamous cell carcinoma
DMM Disease Models and Mechanisms, Vol. 15, Núm. 1
2021
-
In vitro assessment of the role of p53 on chemotherapy treatments in neuroblastoma cell lines
Pharmaceuticals, Vol. 14, Núm. 11
-
Splicing Factor SLU7 Prevents Oxidative Stress-Mediated Hepatocyte Nuclear Factor 4α Degradation, Preserving Hepatic Differentiation and Protecting From Liver Damage
Hepatology, Vol. 74, Núm. 5, pp. 2791-2807
2013
2011
-
Transcriptional regulation of type 11 17β-hydroxysteroid dehydrogenase expression in prostate cancer cells
Molecular and Cellular Endocrinology, Vol. 339, Núm. 1-2, pp. 45-53
2010
-
Type 10 17β-hydroxysteroid dehydrogenase expression is regulated by C/EBPβ in HepG2 cells
Journal of Steroid Biochemistry and Molecular Biology, Vol. 122, Núm. 4, pp. 164-171
2009
-
Estradiol induces type 8 17β-hydroxysteroid dehydrogenase expression: Crosstalk between estrogen receptor α and C/EBPβ
Journal of Endocrinology, Vol. 200, Núm. 1, pp. 85-92
2007
-
Transcriptional regulation of the human type 8 17β-hydroxysteroid dehydrogenase gene by C/EBPβ
Journal of Steroid Biochemistry and Molecular Biology, Vol. 105, Núm. 1-5, pp. 131-139